Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675515 · ClinicalTrials.gov registry record · NA
CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04675515: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT04675515 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04675515, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.
Primary Outcome
Change in smoking status (from smoking to not smoking) of those in an intensive tobacco treatment program at 30 days, 3 months and 6 months
Interventions
- BEHAVIORAL Intensive Tobacco Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2024-02-16 |
| Phase | NA |
What the finished NCT04675515 record still lists
NCT04675515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Intensive Tobacco Treatment is the first listed.
NCT04675515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04675515 about?
NCT04675515 is a clinical study titled "CORE: CO Monitoring for Reach and Efficacy in Tobacco Treatment for Cancer Patients". The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.
What is the current status of trial NCT04675515?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2021-01-19. Estimated completion is 2024-02-16.
What interventions are being tested in trial NCT04675515?
The interventions under investigation include: Intensive Tobacco Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04675515?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04675515's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI